Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
85.61
-2.68 (-3.04%)
At close: Apr 24, 2026, 4:00 PM EDT
87.41
+1.80 (2.10%)
After-hours: Apr 24, 2026, 6:12 PM EDT
Apogee Therapeutics Employees
Apogee Therapeutics had 261 employees as of December 31, 2025. The number of employees increased by 65 or 33.16% compared to the previous year.
Employees
261
Change (1Y)
65
Growth (1Y)
33.16%
Revenue / Employee
n/a
Profits / Employee
-$980,241
Market Cap
6.32B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 261 | 65 | 33.16% |
| Dec 31, 2024 | 196 | 105 | 115.38% |
| Dec 31, 2023 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunovant | 362 |
| Kymera Therapeutics | 238 |
| Arcellx | 209 |
| Celcuity | 155 |
| CG Oncology | 142 |
| Protagonist Therapeutics | 132 |
| Centessa Pharmaceuticals | 118 |
| Erasca | 103 |
APGE News
- 4 weeks ago - Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $403 Million - GlobeNewsWire
- 4 weeks ago - Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering - GlobeNewsWire
- 4 weeks ago - Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering - GlobeNewsWire
- 4 weeks ago - Apogee Therapeutics Stock Rallies On Encouraging Eczema Drug Data Readout - Benzinga
- 4 weeks ago - Apogee Therapeutics Transcript: Study result - Transcripts
- 4 weeks ago - Apogee Therapeutics Announces Positive Phase 2 Part A 52-Week Data of Zumilokibart (APG777), Demonstrating Maintenance and Deepening of Responses with Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic Dermatitis - GlobeNewsWire
- 4 weeks ago - Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026 - GlobeNewsWire
- 7 weeks ago - Apogee Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts